Pyxis Oncology, Inc. (PYXS) Operating income 2020–2025
Pyxis Oncology, Inc. (PYXS) annual operating income history from SEC filings — each fiscal year as reported.
-$84.4MFY2025 · since FY2020: -$12.9M → -$84.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$84.4M | +5.6% |
| FY2024 | -$89.5M | -8.8% |
| FY2023 | -$82.2M | +33.4% |
| FY2022 | -$123.5M | -77.1% |
| FY2021 | -$69.7M | -440.7% |
| FY2020 | -$12.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PYXS financial trends
PYXS RevenuePYXS Net incomePYXS Net marginPYXS Gross profitPYXS Gross marginPYXS Operating marginPYXS Operating cash flowPYXS Free cash flowPYXS Capital expendituresPYXS Return on equityPYXS Stock buybacksPYXS Dividends paidPYXS Total assetsPYXS Total liabilitiesPYXS Shareholders’ equityPYXS overview →